Pembrolizumab and Trametinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer and KRAS Gene Mutations

Clinical trial NCT03299088 · COMPLETED

Trial details

NCT number: NCT03299088
Sponsor: Jonathan Riess
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

KRAS Gene Mutation Metastatic Non-Squamous Non-Small Cell Lung Carcinoma Recurrent Non-Squamous Non-Small Cell Lung Carcinoma Stage IV Non-Small Cell Lung Cancer AJCC v7

Start date: 2018-06-26
Primary completion: 2021-01-28
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.